53 results on '"Vincenzi B"'
Search Results
2. ‘All action no talk’: the role of HER2/neu in adjuvant therapy choice for gastric cancer
3. Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patients
4. Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis
5. Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
6. Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study
7. Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network
8. Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer
9. Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients
10. Role of KRAS let-7 LCS6 SNP in metastatic colorectal cancer patients
11. Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization
12. Genetic modulation of the Let-7 microRNA binding to KRAS 3′-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan
13. High concordance of BRAF status between primary colorectal tumours and related metastatic sites: implications for clinical practice
14. Potential role of everolimus in inducing cholestasis
15. Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients
16. Classification of biliary tract cancer (BTC): evaluation of all entities
17. Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer
18. Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients
19. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes
20. Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer
21. Mucin 2 (MUC2) and mucin 5 (MUC5) expression is not associated with prognosis in patients with radically resected ampullary carcinoma
22. Occasional FDG–PET recognition of in situ breast cancer
23. Fibronectin and laminin expression in sentinel lymph nodes of patients with malignant melanoma
24. COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification
25. New developments of aminobisphosphonates: the double face of Janus
26. A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients
27. A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss
28. COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables
29. Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients
30. Lack of response of cetuximab plus oxaliplatin in advanced colorectal cancer patients resistant to both oxaliplatin and cetuximab plus irinotecan
31. Vascular endothelial growth factor (VEGF) expression is not associated with prognosis in patients with radically resected ampullary carcinoma
32. Cell cycle related proteins as prognostic parameters in radically resected non-small cell lung cancer
33. COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features
34. Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma
35. Weekly oxaliplatin, fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer (AGC): 4237
36. Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB–IIA non-small cell lung cancer
37. Prognostic significance of cyclooxygenase-2 (COX-2) and expression of cell cycle inhibitors p21 and p27 in human pleural malignant mesothelioma
38. Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA–IIIB) non-small-cell lung cancer: long-term results according to downstaging
39. Anaphylaxis to dexrazoxane (ICRF-187) following three previous uncomplicated infusions
40. Analysis of cell cycle regulator proteins in non-small cell lung cancer
41. Dramatic improvement of psoriasis with gemcitabine monotherapy
42. A NEW DOSE-INTENSE EPOETIN-ALPHA REGIMEN IN ANEMIC CANCER PATIENTS RECEIVING CHEMOTHERAPY: AN OPEN-LABEL, NON-RANDOMIZED, PILOT STUDY
43. S-ADENOSYLMETHIONINE (ADOMET) SUPPLEMENTATION FOR TREATMENT OF CHEMOTHERAPY-INDUCED LIVER INJURY
44. PATHOGENESIS OF FEVER RELATED TO ZOLEDRONIC ACID ADMINISTRATION
45. CONTINUOUS INFUSION OF OXALIPLATIN PLUS CHRONO-MODULATED ORAL CAPECITABINE IN ADVANCED COLORECTAL CANCER (CRC): A FEASIBILITY STUDY
46. The antineoplastic role of bisphosphonates: from basic research to clinical evidence
47. Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patients
48. Fatal Thrombocytopenia and Thrombocytopathia: An Unusual Onset of Non Small Cell Lung Cancer
49. Bisphosphonates: new antiangiogenic molecules in cancer treatment?
50. Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.